ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,222.68
0.16%
US Tech 100
17,650.00
0.05%
다우존스 지수
39,512.84
0.32%
Bitcoin
61,631.83
1.37%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Puma Biotechnology Inc (PBYI)

  7. Puma Biotechnology Inc (PBYI) 뉴스

PBYI Puma Biotechnology Inc

4.97
0.18 (3.76%)
11 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Puma Biotechnology Inc PBYI 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.18 3.76% 4.97 13:00:12
개장가 저가 고가 종가 전일 종가
4.79 4.70 4.91 4.81 4.79
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202405:05BWPuma Biotechnology Reports First Quarter Financial Results
19/04/202405:15BWPuma Biotechnology to Host Conference Call to Discuss First..
04/04/202406:30BWPuma Biotechnology Reports Inducement Awards Under Nasdaq..
20/03/202421:30BWPuma Biotechnology Announces FDA Allowance to Proceed Under..
01/03/202406:16EDGAR2Form 8-K - Current report
01/03/202406:05BWPuma Biotechnology Reports Fourth Quarter and Full Year 2023..
28/02/202408:30BWPuma Biotechnology Reports Inducement Awards Under Nasdaq..
23/02/202406:10BWPuma Biotechnology to Participate in a Panel Discussion at..
16/02/202406:10BWPuma Biotechnology to Host Conference Call to Discuss Fourth..
15/02/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202407:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202422:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202422:30BWPuma Biotechnology Announces Initiation of ALISCA-Lung1..
07/02/202405:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/01/202423:00EDGAR2Form 8-K - Current report
12/01/202406:07BWPuma Biotechnology to Present at B. Riley Securities 4th..
11/01/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202406:38EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
06/01/202409:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202408:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202408:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202411:40EDGAR2Form 144 - Report of proposed sale of securities
04/01/202411:39EDGAR2Form 144 - Report of proposed sale of securities
04/01/202411:35EDGAR2Form 144 - Report of proposed sale of securities
04/01/202411:34EDGAR2Form 144 - Report of proposed sale of securities
11/12/202322:30BWPuma Biotechnology Announces Phase II Clinical Trial Design..
07/11/202307:15BWPuma Biotechnology Reports Inducement Awards Under Nasdaq..
03/11/202305:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202305:19EDGAR2Form 8-K - Current report
03/11/202305:05BWPuma Biotechnology Reports Third Quarter 2023 Financial..
20/10/202305:14BWPuma Biotechnology to Host Conference Call to Discuss Third..
15/10/202301:30BWPuma Biotechnology Announces Presentation of Findings from a..
05/10/202306:30BWPuma Biotechnology Reports Inducement Awards Under Nasdaq..
27/09/202305:10EDGAR2Form 8-K - Current report
22/09/202306:02DJNPuma Biotechnology Stock Up 6.9% on New FDA Orphan Drug..
22/09/202305:55DJNPuma Biotechnology Gets Orphan Designation for Small Cell..
22/09/202305:10BWPuma Biotechnology Receives FDA Orphan Drug Designation for..
01/09/202323:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/09/202305:07BWPuma Biotechnology to Present at the H.C. Wainwright 25th..
19/08/202305:17EDGAR2Form 8-K - Current report
08/08/202321:30BWPuma Biotechnology Announces FDA Clearance of IND for..
04/08/202305:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202305:12EDGAR2Form 8-K - Current report
04/08/202305:05BWPuma Biotechnology Reports Second Quarter Financial Results
21/07/202305:15BWPuma Biotechnology to Host Conference Call to Discuss Second..
07/07/202308:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/07/202308:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
PBYI
Puma Biotechnology
BIT
ECE
UBS LUX FUND SOL - BBG M...
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유